⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AZN News
AstraZeneca PLC
Cancer Cachexia Market Outlook Report 2026-2030: Personalized Treatments and Digital Tools Elevate Cancer Cachexia Care; Total Revenue to Grow by $600 Million
globenewswire.com
PFE
MRK
ABBV
AZN
SNY
Non-Small Cell Lung Cancer (NSCLC) Global Market Trends and Regional Growth Insights 2026-2030: Rapid Adoption of Targeted Therapies and Immunotherapy Fuels Market Expansion, Reaching $70.8 Billion by 2030
globenewswire.com
PFE
MRK
ABBV
NVS
SNY
BMY
AZN
GSK
New Nature-Published Research Reviews How Metabolic Dysfunction May Be Core Driver in Psychiatric Diseases
businesswire.com
LULU
AZN
LLY
Институт Critical Path Institute запускает программу One to Millions, чтобы изменить будущее персонализированной медицины в глобальном масштабе USA - Pусский USA - English USA - English USA - Français USA - slovenčina USA - Polski USA - español USA -
prnewswire.com
BMY
MRK
PFE
GILD
REGN
AZN
NVS
BIIB
ALKS
CRIS
EDIT
NTLA
Pelvic Cancer Induced Hemorrhagic Cystitis Market Poised for Very Strong Growth: Expected to Reach $7.98 Billion by 2030
globenewswire.com
PFE
JNJ
MRK
ABBV
SNY
BMY
AZN
NVS
AMGN
Radiation Oncology Market Outlook Report 2026-2030: Industry Anticipated to Reach $13.5 Billion by 2030
globenewswire.com
GEHC
AZN
Tozorakimab met primary endpoint in both OBERON and TITANIA Phase III trials in patients with COPD
businesswire.com
AZN
Neuroprotective Agents Market to Reach $60.9 Billion by 2030 as Neurological Disease Burden and Aging Populations Drive Pharmaceutical Investment
globenewswire.com
ABBV
AZN
BIIB
BMY
GSK
LLY
MRK
NVS
SNY
TEVA
UCB
Inveniam Hires Former Bloomberg and Moody's Leader to Meet Rising Institutional Demand for AI-Ready Data
prnewswire.com
IBM
MUFG
MS
GS
JPM
BAC
WFC
SCHW
AMTD
AXP
V
MA
PYPL
COF
SYK
BMY
PFE
MRK
JNJ
UNH
CVS
CI
AMGN
GILD
BIIB
REGN
AZN
NVS
TSM
NVDA
INTC
AMD
QCOM
AMAT
LRCX
MU
ADBE
CRM
GOOG
GOOGL
AMZN
MSFT
AAPL
META
NFLX
CMCSA
T
VZ
DIS
HD
MCD
SBUX
KO
PEP
CAT
BA
GE
XOM
CVX
HSBC
BCS
NYT
BKR
HAL
SLB
COP
EOG
APA
OXY
DVN
Advancements in Novel Immunotherapeutics in The Oncology Battle Ready to Announce with Confidence?
newsfilecorp.com
AEMD
HURA
AZN
ELTX